Global Market Study on Home Infusion Therapy: Needleless Connectors to Witness Highest Growth by 2020

115
Published Date: 2014-07-31

Home Infusion therapy involves administration of intravenous medication into patient’s body at their homes. It involves the use of needle or catheter for proper medication. It is based on doctor’s prescription. It takes place when oral medication is not effective to cure disease. Home infusion therapy helps in reducing time spent in hospitals, nursing homes and clinics. It includes continuous and slow administration of drug, antibiotic, nutrient and other fluid into vein and tissues on a monthly, weekly and daily basis, depending on the condition of patients and therapy being used in treatment. It is provided by trained professionals and nurses. It is an effective and safe alternative for patients care as it provides friendly environment to inpatients which helps in early recovery of patients. Diseases which are cured through infusion therapy include infections which are unresponsive to oral medication, cancer and cancer-related pain, gastrointestinal diseases and dehydration. It is also used for curing diabetes, health failure, cystic fibrosis, dehydration, transplants, acute infections or nutritional support. It also helps in improving medication adherence and reducing unplanned hospital stay. Infusion pump, intravenous set and needleless connectors are some of the infusion devices which are used for medication.


North America has the largest market for home infusion therapy. This is due to rising number of chronic diseases, increasing healthcare costs in the region. Some of the other large markets for home infusion therapy are Japan, China, Germany and the U.S.


The cost of home infusion therapy is less as compared to hospital stay costs. This is a major reason for increasing demand of home infusion therapy. In addition, other factors such as rising aging population and increasing number of chronic diseases such as diabetes and cancer, technology advancement in infusion devices and increasing application of infusion devices in pain relieving are driving the market for home infusion therapy. As a result, the market is expected to grow at a CAGR of about 9.0% from 2014 – 2020. However, increasing risk with patient’s safety and occurrence of mistakes while using infusion devices and issues related to reimbursement policies for home infusion therapy are inhibiting the growth of home infusion therapy market.


Rising acceptance for specialty infusion therapy has opened new opportunity for home infusion therapy market. Increasing number of mergers and acquisitions, increasing uses of ambulatory infusion pump and rising number of product innovations are some of the major trends that have been observed in home infusion therapy market. 


Some of the major companies operating in the home infusion therapy market are Baxter, B. Braun Melsungen AG, Caesarea Medical Electronics, Fresenius Kabi AG, Smiths Medical, CareFusion Corporation, ICU Medical, Inc., JMS Co. Ltd and TERUMO CORPORATION.  


The report segments the market by device: infusion pump, intravenous set and needleless connectors; by application of home infusion therapy: anti-infective/ antibiotics, enteral nutrition, specialty pharmaceuticals, total parental nutrition (TPN), pain management, chemotherapy and hydration infusion pump; by diseases of home infusion therapy: diabetes and cancer; by geographies: North America, Europe, Asia Pacific and Rest of the World (Row). The report provides the market size and forecast for the different segments under these geographies for the period of 2010 to 2020. The report also provides porters five forces analysis of global home infusion therapy market. 

Table of Content


Chapter 1 Preface 9

1.1 Report Description 9

1.2 Research Methodology 10

1.3 Assumptions 10


Chapter 2 Market Synopsis 11


Chapter 3 Porter Five Forces Analysis 13

3.1 Bargaining power of suppliers 13

3.2 Bargaining power of buyers 14

3.3 Threats of new entrants 14

3.4 Threats of substitutes 14

3.5 Intensity of rivalry 14


Chapter 4 Industry Overview 16

4.1 Market Introduction 16

4.2 Market Drivers 17

      4.2.1 Expanding home care market for infusion therapy 17

      4.2.2 Increasing application of infusion devices in pain relieving 18

      4.2.3 Rising aging population and increasing number of chronic diseases 18

      4.2.4 Technology advancement in infusion devices 19

4.3 Impact Analysis of Market Drivers 20

4.4 Market Restraints 20

      4.4.1 Increasing risk for patients safety and occurrence of mistakes while using infusion devices 21

      4.4.2 Issues related to reimbursement policies for home infusion therapy 21

4.5 Impact Analysis of Market Restraints 22

4.6 Opportunities 22

      4.6.1 Rise in acceptance for speciality infusion therapy 22

4.7 Market Trends 23

      4.7.1 Increasing numbers of mergers and acquisitions 23

      4.7.2 Increasing uses of ambulatory infusion pump 23

4.8 Rising number of product innovations 24


Chapter 5 Market Size and Forecast by type of device 26

5.1 Infusion Pumps 28

5.2 Intravenous Sets 29

5.3 Needleless connectors 31


Chapter 6 Market Size and Forecast of Infusion pumps by devices 33

6.1 Volumetric infusion pump 35

6.2 Syringe infusion pump 37

6.3 Insulin Infusion pump 39

6.4 Enteral Infusion pump 40

6.5 Ambulatory Infusion pump 42

6.6 Patient Control Analgesia (PCA) Infusion 44

6.7 Implantable Infusion pump 46


Chapter 7 Market Size and Forecast by Application 48

7.1 Anti- infectives/ antibiotics 51

7.2 Enteral Nutrition 53

7.3 Speciality Pharmaceuticals 55

7.4 Total Parenteral Nutrition (TPN) 56

7.5 Pain Management 58

7.6 Chemotherapy 60

7.7 Hydration infusion pump 62


Chapter 8 Market Size and Forecast by Type of disease 64

8.1 Diabetes 65

8.2 Cancer 67


Chapter 9 Market Size and Forecast by Region 69

9.1 Global 69

9.2 North America 71

9.3 Europe 74

9.4 Asia 78


Chapter 10 Competitive Scenario 81


Chapter 11 Company Profiles 83

      11.1.1 Overview 83

      11.1.2 Products & Services 83

      11.1.3 Financial Performance 85

      11.1.4 Recent Developments 85

11.2 B. Braun Melsungen AG 86

      11.2.1 Overview 86

      11.2.2 Products & Services 86

      11.2.3 Financial Performance 89

      11.2.4 Recent Developments 89

11.3 Caesarea Medical Electronics 90

      11.3.1 Overview 90

      11.3.2 Products & Services 90

      11.3.3 Financial Performance 91

      11.3.4 Recent Developments 91

11.4 Fresenius Kabi AG 92

      11.4.1 Overview 92

      11.4.2 Products & Services 92

      11.4.3 Financial Performance Fresenius Kabi AG 94

      11.4.4 Recent Developments 94

11.5 Smiths Medical 95

      11.5.1 Overview 95

      11.5.2 Products and Services 95

      11.5.3 Financial Performance 97

      11.5.4 Recent Developments 97

11.6 CareFusion Corporation 98

      11.6.1 Overview 98

      11.6.2 Products & Services 98

      11.6.3 Financial Performance 99

      11.6.4 Recent Developments 100

11.7 ICU Medical, Inc. 101

      11.7.1 Overview 101

      11.7.2 Products & Services 102

      11.7.3 Financial Performance 102

      11.7.4 Recent Developments 103

11.8 JMS Co. Ltd. 104

      11.8.1 Overview 104

      11.8.2 Products & Services 104

      11.8.3 Financial Performance 105

      11.8.4 Recent Developments 106

11.9 Baxter 106

      11.9.1 Overview 106

      11.9.2 Products & Services 107

      11.9.3 Financial Performance 108

      11.9.4 Recent Developments 108

11.10 TERUMO CORPORATION 109

      11.10.1 Overview 109

      11.10.2 Products & Services 109

      11.10.3 Financial Performance 110

      11.10.4 Recent Developments 110


List of Tables


TABLE 1 Market Snapshot: Global market of home infusion therapy (2014 & 2020) 12

TABLE 2 Drivers for home infusion therapy market: Impact analysis 20

TABLE 3 Restraints for home infusion therapy market: Impact analysis 22

TABLE 4 Some major mergers and acquisitions in home infusion therapy market 23

TABLE 5 Some of the products launched by various companies 25

TABLE 6 Global home infusion therapy market, by device 2010 – 2013 (USD million) 26

TABLE 7 Global home infusion therapy market, by device 2014 – 2020 (USD million) 27

TABLE 8 Global infusion pumps market, by region 2010 – 2013 (USD million) 28

TABLE 9 Global infusion pumps market, by region 2014 – 2020 (USD million) 29

TABLE 10 Global intravenous set market, by region 2010 – 2013 (USD million) 30

TABLE 11 Global intravenous set market, by region 2014 – 2020 (USD million) 30

TABLE 12 Global needleless connector market, by region 2010 – 2013 (USD million) 31

TABLE 13 Global needleless connector market, by region 2014 – 2020 (USD million) 32

TABLE 14 Global infusion pumps market, by device 2010 – 2013 (USD million) 34

TABLE 15 Global infusion pump market, by device 2014 – 2020 (USD million) 35

TABLE 16 Global volumetric infusion pump market, by region 2010 – 2013 (USD million) 36

TABLE 17 Global volumetric infusion pump market, by region 2014 – 2020 (USD million) 37

TABLE 18 Global syringe market, by region 2010 – 2013 (USD million) 38

TABLE 19 Global syringe market, by region 2014 – 2020 (USD million) 38

TABLE 20 Global insulin infusion pump market, by region 2010 – 2013 (USD million) 39

TABLE 21 Global insulin infusion pump market, by region 2014 – 2020 (USD million) 40

TABLE 22 Global enteral infusion pump market, by region 2010 – 2013 (USD million) 41

TABLE 23 Global enteral infusion pump market, by region 2014 – 2020 (USD million) 42

TABLE 24 Global ambulatory infusion pump market, by region 2010 – 2013 (USD million) 43

TABLE 25 Global ambulatory infusion pump market, by region 2014 – 2020 (USD million) 44

TABLE 26 Global PCA infusion pump market, by region 2010 – 2013 (USD million) 45

TABLE 27 Global PCA infusion pump market, by region 2014 – 2020 (USD million) 45

TABLE 28 Global implantable infusion pump market, by region 2010 – 2013 (USD million) 46

TABLE 29 Global implantable infusion pump market, by region 2014 – 2020 (USD million) 47

TABLE 30 Global home infusion therapy market, by application 2010 – 2013 (USD million) 49

TABLE 31 Global home infusion therapy market, by application 2014 – 2020 (USD million) 50

TABLE 32 Global anti- infective market, by region 2010 – 2013 (USD million) 51

TABLE 33 Global anti- infective market, by region 2014 – 2020 (USD million) 52

TABLE 34 Global enteral nutrition market, by region 2010 – 2013 (USD million) 53

TABLE 35 Global enteral nutrition market, by region 2014 – 2020 (USD million) 54

TABLE 36 Global speciality pharmaceuticals market, by region 2010 – 2013 (USD million) 55

TABLE 37 Global speciality pharmaceuticals market, by region 2014 – 2020 (USD million) 56

TABLE 38 Global TPN market, by region 2010 – 2013 (USD million) 57

TABLE 39 Global TPN market, by region 2014 – 2020 (USD million) 58

TABLE 40 Global pain management market, by region 2010 – 2013 (USD million) 59

TABLE 41 Global pain management market, by region 2014 – 2020 (USD million) 60

TABLE 42 Global chemotherapy market, by region 2010 – 2013 (USD million) 61

TABLE 43 Global chemotherapy market, by region 2014 – 2020 (USD million) 61

TABLE 44 Global hydration market, by region 2010 – 2013 (USD million) 62

TABLE 45 Global hydration market, by region 2014 – 2020 (USD million) 63

TABLE 46 Global home infusion therapy market, by diseases 2010 – 2013 (USD million) 64

TABLE 47 Global home infusion therapy market, by diseases 2014 – 2020 (USD million) 65

TABLE 48 Global diabetes market, by region 2010 – 2013 (USD million) 66

TABLE 49 Global diabetes market, by region 2014 – 2020 (USD million) 66

TABLE 50 Global cancer market, by region 2010 – 2013 (USD million) 67

TABLE 51 Global cancer market, by region 2014 – 2020 (USD million) 68

TABLE 52 Global home infusion therapy market, by region 2010 – 2013 (USD million) 70

TABLE 53 Global home infusion therapy market, by region 2014 – 2020 (USD million) 71

TABLE 54 North American home infusion therapy market, by country 2010 – 2013 (USD million) 73

TABLE 55 North American home infusion therapy market, by country 2014 – 2020 (USD million) 73

TABLE 56 European home infusion therapy market, by country 2010 – 2013 (USD million) 76

TABLE 57 European home infusion therapy market, by country 2014 – 2020 (USD million) 77

TABLE 58 Asian home infusion therapy market, by country 2010 – 2013 (USD million) 79

TABLE 59 Asian home infusion therapy market, by region 2014 – 2020 (USD million) 80

TABLE 60 Hospira, Inc.’s Product and Service Categories 84

TABLE 61 B. Braun Melsungen AG’s Product and Service Categories 87

TABLE 62 Caesarea Medical Electronics’ Product Categories 91

TABLE 63 Fresenius Kabi AG’s Product Categories 93

TABLE 64 Smiths Medical’s Product Categories 96

TABLE 65 CareFusion Corporation’s Product Categories 99

TABLE 66 ICU Medical, Inc.’s Product Categories 102

TABLE 67 JMS Co. Ltd.’s product categories 105

TABLE 68 Baxter’s Product Categories 107

TABLE 69 TERUMO CORPORATION Product Categories 109


List of Figures 


FIG. 1 Home Infusion Therapy Market: Porter’s five forces analysis 13

FIG. 2 Home infusion therapy market, by devices 16

FIG. 3 Geriatric population in major countries, % in older ages (2000-2050) 19

FIG. 4 Global home infusion therapy Market, by device 2013 (% share) 26

FIG. 5 Global infusion pumps market, by devices 2013 (% share) 33

FIG. 6 Global home infusion therapy Market, by application 2013 (% share) 48

FIG. 7 Global home infusion therapy Market, by type of disease 2013 (% share) 64

FIG. 8 Global home infusion therapy market, by region 2013 (% share) 69

FIG. 9 North American home infusion therapy market, by country 2013 (% share) 72

FIG. 10 European home infusion therapy market, by country 2013 (% share) 75

FIG. 11 Asian home infusion therapy market, by country 2013 (% share) 78

FIG. 12 Competitive Scenario of home infusion therapy providers (2013) 81

FIG. 13 Hospira, Inc. Net Sales and Net Income 2011 – 2013 (USD million) 85

FIG. 14 B. Braun Melsungen AG Net Sales and Net Income 2011 – 2013 (USD million) 89

FIG. 15 Fresenius Kabi AG Sales and Net Income 2011 – 2013 (USD million) 94

FIG. 16 Smiths Group plc Revenue and Profit 2011-2013 (USD Million) 97

FIG. 17 CareFusion Corporation Revenue and Net Income 2011 – 2013 (USD million) 100

FIG. 18 ICU Medical, Inc. Total Revenue and Net Income 2011 – 2013 (USD million) 103

FIG. 19 JMS Co. Ltd. Net Sales and Net Income 2011 – 2013 (USD million) 105

FIG. 20 Baxter Net Sales and Net Income 2011 – 2013 (USD million) 108

FIG. 21 TERUMO CORPORATION Net Sales and Net Income 2011 – 2013 (USD million) 110

Home Infusion therapy involves administration of intravenous medication into patient’s body at their homes. It involves the use of needle or catheter for proper medication. It is based on doctor’s prescription. It takes place when oral medication is not effective to cure disease. Home infusion therapy helps in reducing time spent in hospitals, nursing homes and clinics. It includes continuous and slow administration of drug, antibiotic, nutrient and other fluid into vein and tissues on a monthly, weekly and daily basis, depending on the condition of patients and therapy being used in treatment. It is provided by trained professionals and nurses. The cost of home infusion therapy is less as compared to hospital stay costs, this helps in increasing demand of home infusion therapy. As a result, the market is expected to grow at a CAGR of about 9.0% from 2014 – 2020.


Some of the major drivers which help in increasing demand for home infusion therapy are rising aging population, increasing number of chronic diseases, expansion of home care market for infusion therapy, technological advancement in infusion devices and increasing application of infusion devices in pain relieving. However, increasing risk with patient’s safety and occurrence of mistakes while using infusion devices and issues related to reimbursement policies for home infusion therapy are some factors inhibiting the growth of the home infusion therapy market.


North America has the largest market for home infusion therapy followed by Europe. Some of the other fast growing markets for home infusion therapy are Japan, China, Germany and the U.S. Anti-infective/ antibiotics has the largest application based market in the global home infusion market and is expected to grow at a CAGR of about 9.8% from 2014 – 2020. On the basis of types of devices, home infusion therapy market can be segmented into infusion pump, intravenous set and needleless connectors. 


Baxter is one the leading player in the home infusion therapy market. Other major players in home infusion therapy market are B. Braun Melsungen AG, Fresenius Kabi AG, CareFusion Corporation.


global-home-infusion-therapy-market